DIMENSIONAL FUND ADVISORS LP

Position in ORMP — Oramed Pharmaceuticals Inc.

CIK 354204 AUSTIN, TX

Position in ORMP

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$537,909

+$109,069 QoQ

Shares Held

158,209

+5.1% QoQ

Ownership

0.387%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

10 quarters on record

Voting authority Sole 79.08968516329665.ToString("F0")% Shared 20.910314836703346.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

DIMENSIONAL FUND ADVISORS LP holds $5,003,215,874 across 223 Biotechnology names. ORMP ranks #165 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	989,342	$441,780,774
2	REGN	Regeneron Pharmaceuticals, Inc.	513,060	$396,410,676
3	JAZZ	Jazz Pharmaceuticals plc	1,895,215	$358,290,394
4	BMRN	Biomarin Pharmaceutical Inc	3,802,930	$214,827,514
5	ROIV	Roivant Sciences Ltd.	7,475,866	$207,081,486
6	INCY	Incyte Corp	1,975,544	$185,938,199
7	EXEL	Exelixis, Inc.	4,299,597	$184,409,714
8	HALO	Halozyme Therapeutics, Inc.	2,079,827	$134,419,216

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$537,909	158,209	+5.1%	Shares	Sole	2026-05-07
2025-12-31	$428,840	150,471	+2.0%	Shares	Sole	2026-02-12
2025-09-30	$389,365	147,487	-11.6%	Shares	Sole	2025-11-12
2025-06-30	$375,521	166,899	+18.3%	Shares	Sole	2025-08-12
2025-03-31	$301,912	141,081	+18.6%	Shares	Sole	2025-05-13
2024-12-31	$287,967	118,995	+143.8%	Shares	Sole	2025-02-13
2024-09-30	$119,083	48,805	+55.1%	Shares	Sole	2024-11-07
2024-06-30	$80,877	31,470	+52.1%	Shares	Sole	2024-08-09
2024-03-31	$60,432	20,696	-24.1%	Shares	Sole	2024-05-10
2023-09-30	$71,213	27,285	—	Shares	Sole	2023-11-09
No filing history on record for this holder in this stock.